ClinicalTrials.gov record
Suspended Phase 3 Interventional

The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial

ClinicalTrials.gov ID: NCT07197034

Public ClinicalTrials.gov record NCT07197034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Open-Label Extension Study to Assess the Safety and Efficacy of ARD-101 in Patients With Prader-Willi Syndrome

Study identification

NCT ID
NCT07197034
Recruitment status
Suspended
Study type
Interventional
Phase
Phase 3
Lead sponsor
Aardvark Therapeutics, Inc.
Industry
Enrollment
90 participants

Conditions and interventions

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 22, 2024
Primary completion
Feb 28, 2027
Completion
Mar 31, 2027
Last update posted
Mar 18, 2026

2024 – 2027

United States locations

U.S. sites
16
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
Children's of Alabama Birmingham Alabama 35233-1711
Children's Hospital of Orange Country Orange California 92868
Stanford Children's Health Specialty Services Palo Alto California 94304
Rady Children's Hospital San Diego California 92123
Children's Hospital Colorado Denver Colorado 80045-7106
Nemours Children's Clinic Wilmington Wilmington Delaware 19803-3607
UF Shands Children's Hospital Gainesville Florida 32610-3008
Emory University School of Medicine Atlanta Georgia 30322-1047
Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611-2991
The Johns Hopkins Hospital Baltimore Maryland 21287-0005
University of Minnesota Masonic Children's Hospital Minneapolis Minnesota 55102
Maimonides Medical Center Brooklyn New York 11219-2918
NYU Langone Children's Ambulatory Care Center Mineola New York 11501-4077
Vanderbilt University Medical Center Nashville Tennessee 37232-0005
Cook Children's Medical Center Fort Worth Texas 76104
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07197034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 18, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07197034 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →